| The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging L Zecca, A Stroppolo, A Gatti, D Tampellini, M Toscani, M Gallorini, ... Proceedings of the National Academy of Sciences 101 (26), 9843-9848, 2004 | 529 | 2004 |
| Generalized epilepsy: some of its cellular mechanisms differ from those of focal epilepsy P Gloor, RG Fariello Trends in neurosciences 11 (2), 63-68, 1988 | 433 | 1988 |
| Substantia nigra neuromelanin: structure, synthesis, and molecular behaviour L Zecca, D Tampellini, M Gerlach, P Riederer, RG Fariello, D Sulzer Molecular Pathology 54 (6), 414, 2001 | 310 | 2001 |
| The absolute concentration of nigral neuromelanin, assayed by a new sensitive method, increases throughout the life and is dramatically decreased in Parkinson's disease L Zecca, R Fariello, P Riederer, D Sulzer, A Gatti, D Tampellini FEBS letters 510 (3), 216-220, 2002 | 294 | 2002 |
| Safinamide: from molecular targets to a new anti-Parkinson drug C Caccia, R Maj, M Calabresi, S Maestroni, L Faravelli, L Curatolo, ... Neurology 67 (7_suppl_2), S18-S23, 2006 | 225 | 2006 |
| Studies on lipid peroxidation in the rat brain M Cini, RG Fariello, A Bianchetti, A Moretti Neurochemical research 19, 283-288, 1994 | 175 | 1994 |
| A proposed dual role of neuromelanin in the pathogenesis of Parkinson’s disease L Zecca, FA Zucca, A Albertini, E Rizzio, RG Fariello Neurology 67 (7_suppl_2), S8-S11, 2006 | 159 | 2006 |
| Nigral degeneration in acquired immune deficiency syndrome (AIDS) MG Reyes, F Faraldi, CS Senseng, C Flowers, R Fariello Acta neuropathologica 82, 39-44, 1991 | 156 | 1991 |
| Potentiation of kainic acid epileptogenicity and sparing from neuronal damage by an NMDA receptor antagonist RG Fariello, GT Golden, GG Smith, PF Reyes Epilepsy research 3 (3), 206-213, 1989 | 155 | 1989 |
| C-terminal Agrin Fragment as a potential marker for sarcopenia caused by degeneration of the neuromuscular junction M Drey, CC Sieber, JM Bauer, W Uter, P Dahinden, RG Fariello, ... Experimental gerontology 48 (1), 76-80, 2013 | 149 | 2013 |
| Structural characteristics of human substantia nigra neuromelanin and synthetic dopamine melanins KL Double, L Zecca, P Costi, M Mauer, C Griesinger, S Ito, ... Journal of neurochemistry 75 (6), 2583-2589, 2000 | 147 | 2000 |
| Familial and acquired paroxysmal dyskinesias: a proposed classification with delineation of clinical features DJ Goodenough, RG Fariello, BL Annis, RWM Chun Archives of neurology 35 (12), 827-831, 1978 | 135 | 1978 |
| Synthesis and anticonvulsant activity of a new class of 2-[(arylalkyl) amino] alkanamide derivatives P Pevarello, A Bonsignori, P Dostert, F Heidempergher, V Pinciroli, ... Journal of medicinal chemistry 41 (4), 579-590, 1998 | 127 | 1998 |
| Improvement of motor function in early Parkinson disease by safinamide F Stocchi, G Arnold, M Onofrj, H Kwiecinski, A Szczudlik, A Thomas, ... Neurology 63 (4), 746-748, 2004 | 126 | 2004 |
| The neuromelanin of human substantia nigra and its interaction with metals L Zecca, D Tampellini, A Gatti, R Crippa, M Eisner, D Sulzer, S Ito, ... Journal of neural transmission 109, 663-672, 2002 | 123 | 2002 |
| Elevated levels of a C-terminal agrin fragment identifies a new subset of sarcopenia patients S Hettwer, P Dahinden, S Kucsera, C Farina, S Ahmed, R Fariello, M Drey, ... Experimental gerontology 48 (1), 69-75, 2013 | 120 | 2013 |
| Pharmacokinetics and pharmacodynamics of safinamide, a neuroprotectant with antiparkinsonian and anticonvulsant activity A Marzo, L Dal Bo, NC Monti, F Crivelli, S Ismaili, C Caccia, C Cattaneo, ... Pharmacological research 50 (1), 77-85, 2004 | 120 | 2004 |
| The distribution and role of carnitine in the mammalian brain AL Shug, MJ Schmidt, GT Golden, RG Fariello Life sciences 31 (25), 2869-2874, 1982 | 120 | 1982 |
| Regional distribution of heme oxygenase, HSP70, and glutathione in brain: relevance for endogenous oxidant/antioxidant balance and stress tolerance V Calabrese, G Scapagnini, A Ravagna, RG Fariello, AM Giuffrida Stella, ... Journal of neuroscience research 68 (1), 65-75, 2002 | 118 | 2002 |
| Symptom relief in Parkinson disease by safinamide: biochemical and clinical evidence of efficacy beyond MAO-B inhibition F Stocchi, L Vacca, P Grassini, MF De Pandis, G Battaglia, C Cattaneo, ... Neurology 67 (7_suppl_2), S24-S29, 2006 | 102 | 2006 |
